Michigan Medicine's Health Lab blog sat down with Brian Callaghan, M.D., M.S., who led a team that discovered that high costs and similar effectiveness (to current medications) have led doctors to choose to not utilize the latest neurologic drug therapies.
Members of the NeuroNetwork for Emerging Therapies share what they are thankful for.
Dr. Elafros was interviewed by the Michigan State University Honors College about: "Honors Experiences Inspire Career in Neurology."
Recently the "Killing Me Softly" singer announced her ALS diagnosis which has left her unable to sing. Healthline sat down with Stephen Goutman, M.D., to discuss the effect of the disease and new ALS research on the horizon.
A team from the NeuroNetwork for Emerging Therapies seeks to learn why so many cases of the disease go undiagnosed, threatening the health and often the lives of patients, through a partnership with Hurley Medical Center in Flint.
The article covers recently published findings by a team led by Drs. Eva Feldman and Stephen Goutman and Eva Feldman found that work as a welder, production line work, and jobs that involve exposure to metals, solvents or pesticides are associated with a higher risk for developing ALS.
There was quite a large contingent from Michigan Medicine at the National Academy of Medicine’s Annual Meeting this year, including a number of new inductees. The focus of the events this year was on the importance of climate change and health.
Those who were involved in the incredible work of the International Diabetic Neuropathy Consortium joined to celebrate their extraordinary accomplishments.
Brian Callaghan, M.D., sat down with Michigan Medicine's Michigan Health blog to share alternative treatments for chronic pain and the importance of steering clear of opioids.
Three members from the University of Michigan's Center for Global Health Equity recently received awards for their impact on "teaching, mentoring service and scholarship." The Center celebrates the trio that included Eva Feldman, M.D., Ph.D., who won a Distinguished University Professorship.
Michigan Medicine's Health Lab's Lab Report shared new findings from the NeuroNetwork for Emerging therapies that certain blood lipid profiles can predict the risk of nerve damage 10 years later in patients with type 2 diabetes.
U.S. News & World Report covered important new findings by Dr. Stephen Goutman about which occupations increase ALS risk.
The NeuroNetwork for Emerging Therapies, led by primary investigators Eva Feldman, M.D., Ph.D., and Junghuk Hur, Ph.D., M.S., will look at dietary interventions and the mechanisms underlying their benefits with a new R01 grant from the National Institute of Diabetes and Digestive and Kidney Diseases.
On site of the American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) this morning, Brian Callaghan, M.D., M.S., shared via video a few key points from the talk he had just finished that shared the new American Academy of Neurology (ANN) Painful Diabetic Neuropathy guidelines.
Michigan Medicine's Health Lab's Lab Report shared a recent study by Stephen Goutman, M.D., that found that ALS risk is higher among production workers, those exposed to metals, and volatile compounds on the job due to Michigan's legacy industry and agriculture.
Portraits of Drs. Eva Feldman and Stephen Goutman, directors of the ALS Center of Excellence and Pranger ALS Clinic respectively, take center stage in newly launched visuals on the research page of the National ALS Registry, part of the Agency for Toxic Substances and Disease Registry (ATSDR) at the Centers for Disease Control and Prevention
The University of Timisoara awarded Dr. Pop Busui Doctor Honoris Causa at a ceremony on campus in Romania attended by a number of dignitaries.
Meet two of the 2022 alumni from the successful mentoring program established by Joel and Shelley Tauber.
